Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,713 | 340 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $764.74 | 44 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $710.82 | 37 | $0 (2024) |
| Medtronic Vascular, Inc. | $677.71 | 30 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $630.30 | 29 | $0 (2024) |
| PFIZER INC. | $576.86 | 46 | $0 (2024) |
| Relypsa, Inc. | $400.89 | 24 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $343.70 | 15 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $338.21 | 17 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $293.26 | 17 | $0 (2024) |
| Amgen Inc. | $286.23 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $765.22 | 39 | Boehringer Ingelheim Pharmaceuticals, Inc. ($216.83) |
| 2023 | $489.50 | 19 | Alnylam Pharmaceuticals Inc. ($155.25) |
| 2022 | $61.02 | 3 | Novartis Pharmaceuticals Corporation ($43.69) |
| 2021 | $110.62 | 5 | NOVARTIS PHARMACEUTICALS CORPORATION ($46.96) |
| 2020 | $596.78 | 15 | Bardy Diagnostics, Inc. ($225.00) |
| 2019 | $1,474 | 82 | AstraZeneca Pharmaceuticals LP ($216.29) |
| 2018 | $1,579 | 87 | Medtronic Vascular, Inc. ($272.65) |
| 2017 | $1,636 | 90 | Novartis Pharmaceuticals Corporation ($297.57) |
All Payment Transactions
340 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $29.24 | General |
| 10/16/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: DIABETES | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.62 | General |
| 08/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/31/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.67 | General |
| 07/18/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Cardiology | ||||||
| 06/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: DIABETES | ||||||
| 05/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/15/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $25.89 | General |
| Category: Coronary | ||||||
| 05/15/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Cardiology | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.93 | General |
| 04/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 459 | 666 | $203,774 | $53,690 |
| 2022 | 6 | 299 | 335 | $62,588 | $15,255 |
| 2021 | 4 | 517 | 656 | $31,174 | $7,127 |
| 2020 | 8 | 1,524 | 1,916 | $109,961 | $30,476 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 129 | 226 | $104,412 | $31,551 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 109 | 109 | $55,590 | $13,143 | 23.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 23 | 23 | $15,318 | $3,753 | 24.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 162 | 269 | $18,023 | $2,923 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 25 | $8,625 | $1,887 | 21.9% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 14 | 14 | $1,806 | $432.74 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 71 | 71 | $36,210 | $9,468 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 31 | $10,695 | $3,268 | 30.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 84 | 100 | $6,700 | $1,156 | 17.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 19 | 19 | $3,800 | $951.42 | 25.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 87 | 101 | $2,323 | $327.22 | 14.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 13 | 13 | $2,860 | $83.62 | 2.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 420 | 558 | $12,834 | $3,313 | 25.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 58 | 59 | $11,800 | $3,270 | 27.7% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 17 | 17 | $1,700 | $289.60 | 17.0% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 22 | 22 | $4,840 | $253.89 | 5.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 103 | 139 | $27,913 | $10,094 | 36.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 1,105 | 1,423 | $31,796 | $9,094 | 28.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 108 | 111 | $22,200 | $6,658 | 30.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 102 | 137 | $13,463 | $1,431 | 10.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 28 | 28 | $2,100 | $1,430 | 68.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 25 | 25 | $2,509 | $1,142 | 45.5% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 39 | 39 | $8,580 | $422.59 | 4.9% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 14 | 14 | $1,400 | $204.73 | 14.6% |
About Dr. John Ferullo, MD
Dr. John Ferullo, MD is a Specialist healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528056439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Ferullo, MD has received a total of $6,713 in payments from pharmaceutical and medical device companies, with $765.22 received in 2024. These payments were reported across 340 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($6,713).
As a Medicare-enrolled provider, Ferullo has provided services to 2,799 Medicare beneficiaries, totaling 3,573 services with total Medicare billing of $106,548. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Worcester, MA
- Active Since 10/13/2005
- Last Updated 05/14/2012
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1528056439
Products in Payments
- BRILINTA (Drug) $588.52
- ENTRESTO (Drug) $579.11
- ELIQUIS (Drug) $458.40
- Veltassa (Drug) $400.89
- JARDIANCE (Drug) $373.54
- CHANTIX (Drug) $321.44
- XARELTO (Drug) $293.26
- PRALUENT (Drug) $281.52
- Advisa (Device) $278.60
- PRADAXA (Drug) $256.76
- Carnation Ambulatory Monitor (Device) $225.00
- LEQVIO (Drug) $185.63
- FUROSCIX (Drug) $148.57
- Definity (Drug) $145.60
- Repatha (Biological) $143.24
- Corlanor (Drug) $142.99
- Evera (Device) $126.78
- LifeVest (Device) $121.68
- AMVUTTRA (Drug) $114.30
- VERQUVO (Drug) $112.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Worcester
Dr. Charles Birbara, M.d, M.D
Specialist — Payments: $70,809
Stefanie Goodrich, Pa, PA
Specialist — Payments: $10,294
Dr. Brad Baker, Md, MD
Specialist — Payments: $4,948
Gary Peters, Md, MD
Specialist — Payments: $4,763
Dr. Stephen Desio, M.d, M.D
Specialist — Payments: $3,074
Ms. Kathleen Rose, Pa, PA
Specialist — Payments: $2,294